Position
Chief Financial Officer
Company
Septerna
San FranciscoBiotechnologyHealth CareScience And EngineeringDescription
Septerna, Inc. (Nasdaq: SEPN) has appointed Gil Labrucherie, CFA, J.D., as Chief Financial Officer to lead the finance and legal roles for the company. His extensive expertise in public company finance and capital strategy will be instrumental as the company continues scaling its organization with the advancement of SEP-786 and its broader pipeline of oral small molecule GPCR programs, and expand the applications of its Native Complex Platform™.
Quick answer
Septerna Appoints Gil Labrucherie as Chief Financial Officer (January 6, 2025). Septerna is based in San Francisco, California, United States.
- Who is the new Chief Financial Officer at Septerna?
- Septerna named Gil Labrucherie Chief Financial Officer, announced January 6, 2025.
- What did Septerna announce on January 6, 2025?
- Septerna, Inc. (Nasdaq: SEPN) has appointed Gil Labrucherie, CFA, J.D., as Chief Financial Officer to lead the finance and legal roles for the company. His extensive expertise in public company finance and capital strategy will be instrumental as the company continues scaling its organization with the advancement of SEP-786 and its broader pipeline of oral small molecule GPCR programs, and expand the applications of...
- What does Septerna do?
- Septerna, Inc., is a biotechnology company creating broad new drug discovery opportunities across many disease areas for the abundant drug target class of G protein-coupled receptors (GPCRs).
- Where is Septerna based?
- Septerna is based in San Francisco, California, United States.
- Which similar companies made leadership changes around the same time?
- Cardurion Pharmaceuticals (January 8, 2025), Emmes (January 16, 2025), Kyverna Therapeutics (January 21, 2025) and Envisagenics (February 13, 2025) also announced leadership changes within 45 days of Septerna.
Source: Fundz verified event record.
Other recent leadership changes in Science And Engineering and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Charlotte Newman Joins Cardurion as Chief Business Officer (January 8, 2025)
- Emmes Group Appoints Germaine Gross as Chief Commercial Officer of Emmes Biopharma (January 16, 2025)
- Kyverna Appoints Dr. Naji Gehchan as Chief Medical and Development Officer (January 21, 2025)
- Envisagenics Appoints Sudhir Rao, M.S., MBA as Chief Business Officer to Strengthen Leadership Team (February 13, 2025)
- BlossomHill Therapeutics Appoints Geoff Oxnard as Chief Medical Officer and Executive Vice President, and Ashley Preston as Senior Vice President and Head of Regulatory Affairs and Quality Assurance (January 6, 2025)
- Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer (January 6, 2025)
Who to call at Septerna, and when
A new leader at Septerna brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Septerna raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Septerna, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Septerna. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Septerna changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Septerna changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.